In victory for people with diabetes, Sanofi announces insulin price caps, the last of 3 major insulin makers to do so

Sanofi will cap the price of its most popular insulin, Lantus, at $35 per month for people with private insurance.

The change will take effect Jan. 1, 2024.

About 8.4 million people in the U.S. with diabetes rely on insulin, according to the American Diabetes Association.